Blog

Ketamine and Esketamine for Depression: What is the Ideal Dose? 

The study concludes that for IV ketamine, lower doses within the range of 0.2 to 0.5 mg/kg are effective for treatment-resistant depression without additional benefits at higher doses.

Read More

Bridging New Frontiers in Mental Health: The Synergy of Psychedelic and Ketamine-Assisted Psychotherapies

By embracing the transformative potential of psychedelic and ketamine-assisted psychotherapies, Philadelphia Integrative Psychiatry is at the forefront of providing comprehensive, personalized treatment plans that address the multifaceted needs of our patients.

Read More

Understanding Abilify (Aripiprazole): A Comprehensive Guide

In conclusion, Abilify is a widely used medication in psychiatry with a broad range of applications. It's important to have open and ongoing discussions with your healthcare provider about your treatment plan

Read More
Condition: Depression Dr. David Danish Condition: Depression Dr. David Danish

Harnessing the Power of Psilocybin: A New Frontier in Depression Treatment

The recent advancements in psychedelic-assisted therapy, particularly with substances like psilocybin, signal a promising horizon for treating depression. At Philadelphia Integrative Psychiatry, we are already familiar with the transformative potential of psychedelic therapies through our use of ketamine-assisted treatment.

Read More